Clinical Laserthermia Systems AB (publ) (CLS-B) - Total Liabilities
Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) has total liabilities worth Skr9.92 Million SEK (≈ $1.07 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Clinical Laserthermia Systems AB (publ) - Total Liabilities Trend (2008–2025)
This chart illustrates how Clinical Laserthermia Systems AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. See CLS-B current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Clinical Laserthermia Systems AB (publ) Competitors by Total Liabilities
The table below lists competitors of Clinical Laserthermia Systems AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ebang International Holdings
NASDAQ:EBON
|
USA | $11.73 Million |
|
Nimy Resources Ltd
AU:NIM
|
Australia | AU$4.88 Million |
|
Barramundi Group Ltd
OL:BARRA
|
Norway | Nkr24.80 Million |
|
Interwood-Xylemporia A.T.E.N.E.
AT:XYLEK
|
Greece | €36.40 Million |
|
AIR INDUSTRIES GR.DL-001
F:YH1
|
Germany | €39.13 Million |
|
SRJ Technologies Group Plc
AU:SRJ
|
Australia | AU$1.70 Million |
|
Origin Agritech Ltd
NASDAQ:SEED
|
USA | $151.71 Million |
|
Lunai Bioworks Inc.
NASDAQ:LNAI
|
USA | $20.22 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Clinical Laserthermia Systems AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Clinical Laserthermia Systems AB (publ) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Clinical Laserthermia Systems AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below shows the annual total liabilities of Clinical Laserthermia Systems AB (publ) from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr10.00 Million ≈ $1.08 Million |
-22.30% |
| 2024-12-31 | Skr12.88 Million ≈ $1.39 Million |
-9.31% |
| 2023-12-31 | Skr14.20 Million ≈ $1.53 Million |
-65.91% |
| 2022-12-31 | Skr41.64 Million ≈ $4.48 Million |
-8.59% |
| 2021-12-31 | Skr45.55 Million ≈ $4.90 Million |
+49.50% |
| 2020-12-31 | Skr30.47 Million ≈ $3.28 Million |
-3.79% |
| 2019-12-31 | Skr31.67 Million ≈ $3.41 Million |
+285.61% |
| 2018-12-31 | Skr8.21 Million ≈ $883.85K |
-31.22% |
| 2017-12-31 | Skr11.94 Million ≈ $1.29 Million |
+16.62% |
| 2016-12-31 | Skr10.24 Million ≈ $1.10 Million |
+264.82% |
| 2015-12-31 | Skr2.81 Million ≈ $302.04K |
-47.82% |
| 2014-12-31 | Skr5.38 Million ≈ $578.82K |
+72.97% |
| 2013-12-31 | Skr3.11 Million ≈ $334.63K |
+4.77% |
| 2012-12-31 | Skr2.97 Million ≈ $319.40K |
+36.49% |
| 2011-12-31 | Skr2.17 Million ≈ $234.02K |
+54.76% |
| 2010-12-31 | Skr1.41 Million ≈ $151.22K |
-10.71% |
| 2009-12-31 | Skr1.57 Million ≈ $169.35K |
-14.73% |
| 2008-12-31 | Skr1.85 Million ≈ $198.61K |
-- |
About Clinical Laserthermia Systems AB (publ)
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more